{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:16:00Z","timestamp":1783617360700,"version":"3.55.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory demyelinating autoimmune disorder of the central nervous system that exhibits a broad spectrum of known clinical phenotypes, including optic neuritis, myelitis, acute disseminated encephalomyelitis, encephalitis, meningoencephalitis, and brainstem encephalitis. However, new evidence indicates that a small subset of patients may present with cortical cerebral encephalitis (CCE). When CCE manifests as acute unilateral limb weakness, it may closely mimic acute cerebral infarction (ACI), resulting in misdiagnosis and delayed initiation of immunotherapy. Here, we report a case initially diagnosed as ACI and highlight key diagnostic clues and therapeutic considerations that may help to facilitate earlier recognition and appropriate management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A young woman was admitted with left-sided limb weakness and was initially diagnosed with ACI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The final diagnosis was myelin oligodendrocyte glycoprotein (MOG) antibody-related autoimmune encephalitis, which was established by integrating the clinical presentation, contrast-enhanced brain magnetic resonance imaging (MRI) findings, cerebrospinal fluid (CSF) antibody testing, and systematic exclusion of alternative etiologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>After an initial misdiagnosis, the patient received neuroprotective agents without meaningful improvement. Subsequent lumbar puncture and CSF testing supported the diagnosis of MOG antibody-related autoimmune encephalitis. Treatment was then adjusted to include both high-dose intravenous corticosteroid pulse therapy and immunotherapy, which resulted in marked clinical improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient\u2019s condition remained stable at 2-month follow-up, with no disease progression. Contrast-enhanced MRI showed no abnormalities in the unilateral cerebral cortex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>CCE associated with MOGAD may be misdiagnosed as ACI, particularly when focal motor deficits are the predominant presenting feature. Early recognition, prompt diagnostic evaluation, and timely initiation of immunotherapy are crucial for improving clinical outcomes. Greater clinician awareness and improved neuroimaging-based differentiation between ACI and CCE are therefore needed. In patients with stroke-mimicking presentations but atypical imaging findings, contrast-enhanced MRI and cerebrospinal fluid testing for MOG immunoglobulin G should be prioritized. High-dose steroid pulse therapy combined with immunotherapy remains the recommended first-line treatment for suspected MOG antibody-related autoimmune encephalitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049543","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:00:29Z","timestamp":1783098029000},"page":"e49543","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Myelin oligodendrocyte glycoprotein antibody-related autoimmune encephalitis misdiagnosed as acute cerebral infarction: A case report"],"prefix":"10.1097","volume":"105","author":[{"given":"Congling","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neurology, Bethune International Peace Hospital, Shijiazhuang, Hebei, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxia","family":"Zhi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bethune International Peace Hospital, Shijiazhuang, Hebei, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingze","family":"Zhu","sequence":"additional","affiliation":[{"name":"Cancer Hospital Affiliated to Harbin Medical University, Heilongjiang, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8387-4994","authenticated-orcid":false,"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bethune International Peace Hospital, Shijiazhuang, Hebei, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260709","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria.","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"key":"R2-20260709","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","article-title":"Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease.","volume":"75","author":"Hamid","year":"2018","journal-title":"JAMA Neurol"},{"key":"R3-20260709","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders.","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol"},{"key":"R4-20260709","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jnnp-2023-331137","article-title":"Cerebral enhancement in MOG antibody-associated disease.","volume":"95","author":"Elsbernd","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-20260709","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/ene.13790","article-title":"Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China.","volume":"26","author":"Wang","year":"2019","journal-title":"Eur J Neurol"},{"key":"R6-20260709","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease.","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"R7-20260709","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm1488","article-title":"Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.","volume":"13","author":"O\u2019Connor","year":"2007","journal-title":"Nat Med"},{"key":"R8-20260709","doi-asserted-by":"crossref","first-page":"e2142780","DOI":"10.1001\/jamanetworkopen.2021.42780","article-title":"Factors associated with relapse and treatment of myelin oligodendrocyte glycoprotein antibody-associated disease in the United Kingdom.","volume":"5","author":"Satukijchai","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R9-20260709","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s00415-019-09440-8","article-title":"Unilateral cortical FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome.","volume":"266","author":"Budhram","year":"2019","journal-title":"J Neurol"},{"key":"R10-20260709","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R11-20260709","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.25957","article-title":"Silent new brain MRI lesions in children with MOG-antibody associated disease.","volume":"89","author":"Fadda","year":"2021","journal-title":"Ann Neurol"},{"key":"R12-20260709","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/brain\/awaa102","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.","volume":"143","author":"Takai","year":"2020","journal-title":"Brain"},{"key":"R13-20260709","doi-asserted-by":"crossref","first-page":"e731","DOI":"10.1212\/NXI.0000000000000731","article-title":"Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies.","volume":"7","author":"Wegener-Panzer","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R14-20260709","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/02841851241307330","article-title":"Diagnostic utility of magnetic resonance imaging in autoimmune encephalitis: prognostic implications.","volume":"66","author":"Narayanan Nambiar","year":"2025","journal-title":"Acta Radiol"},{"key":"R15-20260709","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s40478-022-01472-y","article-title":"Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis.","volume":"10","author":"Westfall","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"R16-20260709","doi-asserted-by":"crossref","first-page":"1392992","DOI":"10.3389\/fimmu.2024.1392992","article-title":"Efficacy of steroid therapy in the acute stage of anti-NMDAR and anti-MOG antibody overlapping encephalitis: a case report and literature review.","volume":"15","author":"Kondo","year":"2024","journal-title":"Front Immunol"},{"key":"R17-20260709","doi-asserted-by":"crossref","first-page":"104237","DOI":"10.1016\/j.msard.2022.104237","article-title":"Details and outcomes of a large cohort of MOG-IgG associated optic neuritis.","volume":"68","author":"Chen","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"R18-20260709","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jnnp-2022-330360","article-title":"Time to steroids impacts visual outcome of optic neuritis in MOGAD.","volume":"94","author":"Rode","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R19-20260709","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamaneurol.2022.0489","article-title":"Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease.","volume":"79","author":"Chen","year":"2022","journal-title":"JAMA Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:02:20Z","timestamp":1783616540000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":19,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049543","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"2025-10-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}